N-terminal pro-B-type natriuretic peptide showed the strongest association with heart failure in patients with type 2 diabetes.
All articles by stevebarrett
The least common condition, systemic lupus erythematosus, was associated with the highest association of experiencing multiple cardiometabolic events.
Two-hour postload glucose better predicted cardiovascular events compared with fasting plasma glucose and HbA1c.
Patients with diabetes had higher hospital readmission rates compared with patients who did not have diabetes.
Over 200 patients participated in the study of a novel immunoassay used to distinguish hypertension from hyperaldosteronism.
Two studies examined the effects of naltrexone/bupropion on weight loss, glycemic parameters, and cardiovascular risks in patients with type 2 diabetes.
Patients with type 2 diabetes taking statins after insulin initiation had better glycemic control, but their risk for mortality was higher compared with patients who did not take statins.
Flow mediated dilation changes improved in patients who received dapagliflozin.
Sitagliptin improved glucose excursion and lowered triglyceride levels in men with prediabetes who were also overweight.
Patients with cardiovascular disease and both type 2 diabetes and chronic kidney disease had the highest risk for mortality.